Sensus Healthcare financials
$3.07+2.50%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Dec 31 | FY24 Dec 31 | FY23 Dec 31 | FY22 Dec 31 | FY21 Dec 31 | FY20 Dec 31 | FY19 Dec 31 | FY18 Dec 31 | FY17 Dec 31 | FY16 Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $27.5M | $41.8M | $24.4M | $44.5M | $27.0M | $9.6M | $27.3M | $26.4M | $20.6M | $14.8M |
| Gross profit | $11.9M | $24.4M | $14.1M | $29.6M | $17.0M | $5.2M | $17.6M | $16.9M | $13.8M | $9.8M |
| Gross margin | 43.2% | 58.4% | 57.6% | 66.5% | 62.8% | 54.8% | 64.4% | 64.0% | 67.0% | 66.5% |
| Operating income | -$10.3M | $8.1M | -$382.0K | $14.8M | $4.1M | -$8.2M | -$2.0M | -$2.0M | -$3.7M | -$363.1K |
| Net income | -$7.7M | $6.6M | $485.0K | $24.2M | $4.1M | -$6.8M | -$1.7M | -$2.0M | -$3.7M | -$346.4K |
| Net margin | −28.1% | 15.9% | 2.0% | 54.4% | 15.2% | −71.4% | −6.2% | −7.7% | −18.0% | −2.3% |
| Diluted EPS | $-0.47 | $0.41 | $0.03 | $1.46 | $0.25 | $-0.42 | $-0.10 | $-0.14 | $-0.28 | $-0.03 |
| EBITDA | -$9.9M | $8.3M | -$107.0K | $15.1M | $4.7M | -$7.5M | -$1.4M | -$1.3M | -$3.3M | -$25.5K |
| Operating cash flow | $528.0K | -$831.0K | -$2.1M | -$1.4M | -$286.0K | -$434.0K | -$2.1M | -$8.6M | -$3.1M | -$851.0K |
| Free cash flow | $332.0K | -$1.1M | -$2.4M | -$1.6M | -$414.0K | -$793.0K | -$2.5M | -$9.4M | -$3.3M | -$1.1M |
| Diluted shares | 16.3M | 16.4M | 16.3M | 16.6M | 16.5M | 16.4M | 16.2M | 14.1M | 13.2M | 12.0M |
Balance sheet
| Period end | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $22.1M | $22.1M | $23.1M | $25.5M | $14.5M | $14.9M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | — | — |
| Total debt | $0.00 | $0.00 | $0.00 | $0.00 | $51.0K | $267.0K |
| Total assets | $53.0M | $62.2M | $53.7M | $56.7M | $32.2M | $28.0M |
| Total liabilities | $4.9M | $6.3M | $4.9M | $8.7M | $6.2M | $6.5M |
| Shareholders' equity | $48.1M | $55.8M | $48.8M | $48.1M | $26.0M | $21.5M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology